Close Menu

Blind No More?

FDA has given biotech company Advanced Cell Technology the go-ahead to test a treatment for macular degeneration using human embryonic stem cells in a clinical trial, says Jennifer Welsh at the 80beats blog. Researchers at Advanced Cell Technology suggest that implanting hESCs in these patients could end retinal pigment epithelial cell death and reverse blindness; using this approach, the team saw improved vision in rats, Welsh says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.